Formulating a review question g q Montreal Monday May 25 th 2009 - - PowerPoint PPT Presentation

formulating a review question g q
SMART_READER_LITE
LIVE PREVIEW

Formulating a review question g q Montreal Monday May 25 th 2009 - - PowerPoint PPT Presentation

Formulating a review question g q Montreal Monday May 25 th 2009 Montreal, Monday May 25 th , 2009 Mariska Leeflang 1 Dr Mariska Leeflang Dept. Clinical Epidemiology, Biostatistics and Bioinformatics Academic Medical Center, University of


slide-1
SLIDE 1

Formulating a review question g q

Montreal Monday May 25th 2009 Montreal, Monday May 25th, 2009

1

Mariska Leeflang

Dr Mariska Leeflang

  • Dept. Clinical Epidemiology, Biostatistics and

Bioinformatics Academic Medical Center, University of Amsterdam Room J1B – 210 PO Box 227700 1100 DE Amsterdam m.m.leeflang@amc.uva.nl

slide-2
SLIDE 2

E l f i Examples of questions

Director of a diagnostic lab: “Should we purchase this device?” Insurance company: “Should we reimburse this test?” Insurance company: Should we reimburse this test? Guideline developers: “Should we recommend this test?” Head of a clinical department: “How should we use this test?” Patient: “Do I want to undergo this test?” Clinician: “What does this test result mean?”

2

slide-3
SLIDE 3

How should test accuracy be used?

T id tif th b t t t

 To identify the best tests  To identify the best use of tests  To identify the best use of tests  Replacing  In combination  In sequence  Probabilistic thinking  Probabilistic thinking  Combining with evidence of treatment

ff i d i i d l

3

effects in decision models

slide-4
SLIDE 4

Q ti f l ti Question formulation

Objective of a DTA SR can be

 To make comparisons between tests

concerning their global accuracy h f

 To estimate the accuracy of a test operating

at a particular threshold

 To understand why results of studies vary  To understand why results of studies vary

4

slide-5
SLIDE 5

M t ti ti Most questions are comparative

5

slide-6
SLIDE 6

M t ti ti Most questions are comparative

6

slide-7
SLIDE 7

Replacement

If h i d i b i id d

 If the new index test is being considered as

a replacement for the comparator test, we need to consider

 The accuracy of the new index test

(new index test compared to ref std)

 The accuracy of the comparator test  The accuracy of the comparator test

(comparator test compared to ref std)

7

slide-8
SLIDE 8

Add-on

If th i d t t i b i id d

 If the new index test is being considered as

additional to the comparator test, we need to consider:

 The rule which is being used to combine tests

 Either positive  Both positive  A scoring system

 The accuracy of the new index and comparator

tests combined

 The accuracy of the comparator test

8

 The accuracy of the comparator test

slide-9
SLIDE 9

Triage

If the new index test is being considered as a test to

 If the new index test is being considered as a test to

select patients for additional testing using the comparator test, we need to consider:

 The rule which is being used to define patients

who need further testing

 New index test positive

p

 New index test negative

 The accuracy of the triage strategy combining

y g gy g test the new index and comparator tests

 The accuracy of the comparator test

9

slide-10
SLIDE 10

Components of a question

Patients, Presentation, Prior tests I ndex test, Comparator test Purpose: comparative question Purpose: comparative question alternative tests role of test(s) now and future role of test(s) now and future Target disorder, Reference standard

10

slide-11
SLIDE 11

Patients, Presentation, Prior Tests

 Presentation

indicates why the people in the

 Presentation – indicates why the people in the

study received the test, and indicates in what circumstances the results apply

 Sensitivity depends on the spectrum of disease in

those with the target disorder

 important to know whether restricted by prior tests  important to know whether restricted by prior tests,

  • r referral status

 Specificity depends on the spectrum of alternative  Specificity depends on the spectrum of alternative

diseases in those without the target disorder

 important to know whether restricted by prior tests,

  • r referral status

11

slide-12
SLIDE 12

Index and comparator tests

Th i d i h “ ” i h

 The index test is the “new” test we wish to

  • evaluate. A review may consider and

compare several index tests. p

 The comparator test is the alternative

diagnostic management strategy which is standard practice and with which we would like to make comparisons p

12

slide-13
SLIDE 13

Purposes of tests

N i d t t b d i i t

 New index tests can be used in a variety

  • f ways to improve diagnosis.

REPLACEMENT

 They can be used to replace an existing test

ADD ON ADD-ON

 They can be used in addition to an existing test

TRI AGE

 They can be used to decide whether an

existing test should be undertaken

13

slide-14
SLIDE 14

Target disorders and reference standards

 Target disease is the condition we are

trying to diagnose

 May be a pathologically defined condition

May be a pathologically defined condition

 May simply be an indication for treatment

 Reference standard is the best way

y available of identifying target condition

 Work-up or differential verification bias if tests

used in reference diagnosis vary dependent on the result of the index test the result of the index test

 Incorporation bias if index test is part of the

reference diagnosis

14

slide-15
SLIDE 15

B k d d bj ti Background and objectives

 The most common problem we had in the

Editorial Team, was that authors were not clea on the intended ole of the test and clear on the intended role of the test and the expected (or required) accuracy for that role.

 Authors forget to explain what they really

want to know.

15

slide-16
SLIDE 16

Exercise